It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy called "most favored nation."

Late last month, President Donald Trump issued letters to Lilly CEO David Ricks and to the CEOs of roughly a dozen other large pharmaceutical companies, giving them until late September to cut the U.S. prices of certain drugs or the administration will “deploy every tool in our arsenal to protect American families.”

As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly seems willing to play ball. | Eli Lilly said it has "intensified efforts to align prices across developed countries" in recent months.